drugset / Trial / NCT02181309

Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers

NCT02181309

Phase 1 Completed 24 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Study to investigate dose-proportionality over the dosage range 7.5 mg to 22.5 mg, and to assess the effect of food on the pharmacokinetics of meloxicam after a single p.o. administration of 22.5 mg meloxicam oral suspension.

Timeline

Start
2002-01
Primary completion
2002-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule 7.5 mg Oral
Subject Meloxicam Small molecule 22.5 mg Oral

Indications

No indication recorded.